Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2018
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
Emily Y Jen, Qing Xu, Aaron Schetter, et al.
BMC Genomics
|
June 5, 2012
Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development
Tao Han, Ching-Wei Chang, Joshua C Kwekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
The Oncologist
|
June 9, 2020
State of the Science and Future Directions for Liquid Biopsies in Drug Development
Preeti Narayan, Soma Ghosh, Reena Philip, et al.
The Oncologist
|
February 14, 2018
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer
Melanie Royce, Christy Osgood, Flora Mulkey, et al.
The Oncologist
|
December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
JCO Precision Oncology
|
September 11, 2020
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings
Hisani N Horne, Donna Roscoe, E David Litwack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Katie Chon, Erin Larkins, Somak Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2018
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
Emily Y Jen, Qing Xu, Aaron Schetter, et al.
BMC Genomics
|
June 5, 2012
Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development
Tao Han, Ching-Wei Chang, Joshua C Kwekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
The Oncologist
|
June 9, 2020
State of the Science and Future Directions for Liquid Biopsies in Drug Development
Preeti Narayan, Soma Ghosh, Reena Philip, et al.
The Oncologist
|
February 14, 2018
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer
Melanie Royce, Christy Osgood, Flora Mulkey, et al.
The Oncologist
|
December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
JCO Precision Oncology
|
September 11, 2020
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings
Hisani N Horne, Donna Roscoe, E David Litwack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Katie Chon, Erin Larkins, Somak Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Page
of 6